Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 518,163 | 484,960 | 674,493 | 713,523 | 94,210 |
| Marketable Securities | 97,848 | 84,826 | 10,435 | 32,324 | 17,086 |
| Receivables | 14,402 | 10,608 | 3,570 | N/A | N/A |
| Inventories | 6,141 | 4,172 | 2,611 | N/A | N/A |
| Other current assets | 0 | 100,000 | 0 | 0 | 0 |
| TOTAL | $654,666 | $702,135 | $704,645 | $754,027 | $116,908 |
| Non-Current Assets | |||||
| PPE Net | 3,297 | 2,968 | 3,300 | 2,847 | 2,808 |
| Other Non-Current Assets | 21,577 | 22,667 | 17,082 | 17,340 | 16,057 |
| TOTAL | $24,874 | $25,635 | $20,382 | $20,187 | $18,865 |
| Total Assets | $679,540 | $727,770 | $725,027 | $774,214 | $135,773 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,976 | 9,161 | 18,352 | 12,985 | 8,292 |
| Accrued Expenses | 46,334 | 42,938 | 44,612 | 44,377 | 40,141 |
| Other current liabilities | 110,494 | 136,354 | 116,005 | 92,415 | N/A |
| TOTAL | $268,336 | $307,570 | $281,340 | $252,072 | $66,757 |
| Non-Current Liabilities | |||||
| Long Term Debt | 358,700 | 358,700 | 358,700 | 313,700 | 253,700 |
| Deferred Revenues | 100,564 | 117,231 | 100,564 | 100,564 | 16,667 |
| Other Non-Current Liabilities | 9,410 | 9,933 | 41,583 | 60,755 | 15,095 |
| TOTAL | $794,131 | $819,826 | $797,652 | $792,799 | $268,795 |
| Total Liabilities | $1,062,467 | $1,127,396 | $1,078,992 | $1,044,871 | $335,552 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93,309 | 92,078 | 91,480 | 90,799 | 90,594 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,129,399 | -1,107,808 | -1,046,148 | -964,785 | -890,936 |
| Other shareholders' equity | -17,285 | -17,285 | -17,285 | -17,285 | -11,540 |
| TOTAL | $-382,927 | $-399,626 | $-353,965 | $-270,657 | $-199,779 |
| Total Liabilities And Equity | $679,540 | $727,770 | $725,027 | $774,214 | $135,773 |